Nunn Jason Raleigh
SEC insider (Form 3/4/5 filer). CIK 0001444319. Director at Addex Therapeutics Ltd. (ADXN) and 2 other issuers. 12 reported Form 4/5 transactions since Sep 2024; latest on Sep 2, 2026. Located in GENEVA.
Companies Nunn Jason Raleigh has filed insider reports for
- Addex Therapeutics Ltd. (ADXN): Director
- Zenas BioPharma, Inc. (ZBIO): Director
- Regulus Therapeutics Inc. (RGLS): Director
Nunn Jason Raleigh
CIK: 0001444319
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (12 total)
- Sep 2, 2026ADXN
Addex Therapeutics Ltd.
DispositionDirect219.6K shares- - Sep 2, 2026ADXN
Addex Therapeutics Ltd.
AwardDirect219.6K shares- - Jun 15, 2026ZBIO
Zenas BioPharma, Inc.
AwardDirectStock Option (Right to Buy)
18.5K shares- - Oct 9, 2025ZBIO
Zenas BioPharma, Inc.
PurchaseIndirect63.2K shares at avg. $19.00$1.2M - Jun 25, 2025RGLS
Regulus Therapeutics Inc.
DispositionDirect62.5K shares- - Jun 10, 2025ZBIO
Zenas BioPharma, Inc.
AwardDirectStock Option (Right to Buy)
18.5K shares- - Apr 30, 2025RGLS
Regulus Therapeutics Inc.
AwardDirect62.5K shares- - Sep 16, 2024ZBIO
Zenas BioPharma, Inc.
PurchaseIndirect441.2K shares at avg. $17.00$7.5M - Sep 16, 2024ZBIO
Zenas BioPharma, Inc.
ConversionIndirect1.5M shares- - Sep 16, 2024ZBIO
Zenas BioPharma, Inc.
PurchaseIndirect441.2K shares at avg. $17.00$7.5M
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Sep 2, 2026 |  ADXN Addex Therapeutics Ltd. | Disposition | 219,561 | - | $0 | Direct |
| Sep 2, 2026 | ADXN Addex Therapeutics Ltd. | Award | 219,561 | - | $0 | Direct |
| Jun 15, 2026 |  ZBIO Zenas BioPharma, Inc. | Award Stock Option (Right to Buy) | 18,500 | - | - | Direct |
| Oct 9, 2025 | ZBIO Zenas BioPharma, Inc. | Purchase | 63,158 | $19.00 | $1,200,002 | Indirect |
| Jun 25, 2025 |  RGLS Regulus Therapeutics Inc. | Disposition | 62,500 | - | - | Direct |
| Jun 10, 2025 | ZBIO Zenas BioPharma, Inc. | Award Stock Option (Right to Buy) | 18,500 | - | - | Direct |
| Apr 30, 2025 | RGLS Regulus Therapeutics Inc. | Award | 62,500 | - | - | Direct |
| Sep 16, 2024 | ZBIO Zenas BioPharma, Inc. | Purchase | 441,176 | $17.00 | $7,499,992 | Indirect |
| Sep 16, 2024 | ZBIO Zenas BioPharma, Inc. | Conversion | 1,505,388 | - | $0 | Indirect |
| Sep 16, 2024 | ZBIO Zenas BioPharma, Inc. | Purchase | 441,176 | $17.00 | $7,499,992 | Indirect |
1-10 of 12 transactions